(Q47396894)

15 January 2018

title

Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study (English)

1 reference

15 January 2018

1 reference

Ashok K Tuteja

1

1 reference

15 January 2018

John C Fang

2

1 reference

15 January 2018

Manal Al-Suqi

3

1 reference

15 January 2018

Gregory J Stoddard

4

1 reference

15 January 2018

Devon C Hale

5

1 reference

15 January 2018

publication date

12 July 2012

1 reference

15 January 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

15 January 2018

volume

47

1 reference

15 January 2018

issue

10

1 reference

15 January 2018

page(s)

1159-1164

1 reference

15 January 2018

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Lymphocytic colitis: clinical presentation and long term course

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Role of infection in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

The role of psychological and biological factors in postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Distribution of collagenous colitis: utility of flexible sigmoidoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.694903

10.3109/00365521.2012.694903

21 January 2018

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018